Literature DB >> 15149432

Utility of implantable cardioverter defibrillator electrograms to estimate repolarization alternans preceding a tachyarrhythmic event.

Antonis A Armoundas1, Christine M Albert, Richard J Cohen, Theofanie Mela.   

Abstract

Electrical alternans is a pattern of variation in the shape of the ECG waveform that appears on an every-other-beat basis. In humans, alternation in ventricular repolarization, namely, repolarization alternans, has been associated with increased vulnerability to ventricular tachycardia/ventricular fibrillation and sudden cardiac death. This study investigates the utility of implantable cardioverter defibrillator electrograms to estimate repolarization alternans preceding a tachyarrhythmic event. It is demonstrated that microvolt-level repolarization alternans is present prior to an arrhythmic event, and one can record low-amplitude-noise signals that can be used to obtain reliable estimates of repolarization alternans. This study eventually may lead to new methods that would prevent the onset of malignant tachyarrhythmias.

Entities:  

Mesh:

Year:  2004        PMID: 15149432     DOI: 10.1046/j.1540-8167.2004.03411.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  9 in total

Review 1.  Role of substrate and triggers in the genesis of cardiac alternans, from the myocyte to the whole heart: implications for therapy.

Authors:  Faisal M Merchant; Antonis A Armoundas
Journal:  Circulation       Date:  2012-01-24       Impact factor: 29.690

Review 2.  T-wave alternans: reviewing the clinical performance, understanding limitations, characterizing methodologies.

Authors:  Euler de Vilhena Garcia
Journal:  Ann Noninvasive Electrocardiol       Date:  2008-10       Impact factor: 1.468

3.  A novel method for determining the phase of T-wave alternans: diagnostic and therapeutic implications.

Authors:  Omid Sayadi; Faisal M Merchant; Dheeraj Puppala; Theofanie Mela; Jagmeet P Singh; E Kevin Heist; Chris Owen; Antonis A Armoundas
Journal:  Circ Arrhythm Electrophysiol       Date:  2013-07-24

Review 4.  T-wave alternans as an arrhythmic risk stratifier: state of the art.

Authors:  Faisal M Merchant; Omid Sayadi; Kasra Moazzami; Dheeraj Puppala; Antonis A Armoundas
Journal:  Curr Cardiol Rep       Date:  2013-09       Impact factor: 2.931

5.  Real-Time Closed-Loop Suppression of Repolarization Alternans Reduces Arrhythmia Susceptibility In Vivo.

Authors:  Faisal M Merchant; Omid Sayadi; Kwanghyun Sohn; Eric H Weiss; Dheeraj Puppala; Rajiv Doddamani; Jagmeet P Singh; E Kevin Heist; Chris Owen; Kanchan Kulkarni; Antonis A Armoundas
Journal:  Circ Arrhythm Electrophysiol       Date:  2020-05-20

6.  A novel lead configuration for optimal spatio-temporal detection of intracardiac repolarization alternans.

Authors:  Eric H Weiss; Faisal M Merchant; Andre d'Avila; Lori Foley; Vivek Y Reddy; Jagmeet P Singh; Theofanie Mela; Jeremy N Ruskin; Antonis A Armoundas
Journal:  Circ Arrhythm Electrophysiol       Date:  2011-03-23

Review 7.  A translational approach to probe the proarrhythmic potential of cardiac alternans: a reversible overture to arrhythmogenesis?

Authors:  Faisal M Merchant; Omid Sayadi; Dheeraj Puppala; Kasra Moazzami; Victoria Heller; Antonis A Armoundas
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-12-06       Impact factor: 4.733

8.  Utility of a Smartphone Based System (cvrPhone) to Predict Short-term Arrhythmia Susceptibility.

Authors:  Kwanghyun Sohn; Steven P Dalvin; Faisal M Merchant; Kanchan Kulkarni; Furrukh Sana; Shady Abohashem; Jagmeet P Singh; E Kevin Heist; Chris Owen; Eric M Isselbacher; Antonis A Armoundas
Journal:  Sci Rep       Date:  2019-10-10       Impact factor: 4.379

Review 9.  Cardiac Alternans: Mechanisms and Clinical Utility in Arrhythmia Prevention.

Authors:  Kanchan Kulkarni; Faisal M Merchant; Mohamad B Kassab; Furrukh Sana; Kasra Moazzami; Omid Sayadi; Jagmeet P Singh; E Kevin Heist; Antonis A Armoundas
Journal:  J Am Heart Assoc       Date:  2019-10-16       Impact factor: 5.501

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.